Clinical Trial Update: Effect of Dapagliflozin on Inflammation and Endothelial Function [Phase 4]

View source ↗

Summary

Phase 4 trial investigating the effect of dapagliflozin on inflammation and endothelial function in type 2 diabetes mellitus; trial terminated with results post…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Dapagliflozin (dapagliflozin)

Snippet

Sponsor: Baylor College of Medicine | Conditions: Type 2 Diabetes Mellitus | Phase 4 | Status: TERMINATED | Results posted: 2020-04-08